ArticleBMC oral health2026
Cell pellets promote periodontal bone regeneration in furcation involvement by regulating macrophage polarization through TGF-β1 secretion.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundFurcation involvement, a severe complication of chronic periodontitis, poses significant challenges for clinical regeneration because of failure to remodel the inflammatory microenvironment. Current strategies such as guided tissue regeneration are limited by two-dimensional architecture and insufficient immunomodulation, resulting in failure to restore functional periodontal tissues. Cell pellet, a novel scaffold-free technology, features self-assembled three-dimensional structures and endogenous extracellular matrix storing growth factors; however, its immunomodulatory mechanism, particularly with respect to macrophage polarization, remains uncharacterized.
objectiveTo investigate the effects of cell pellets on macrophage polarization and its molecular mechanisms and to validate their in vivo efficacy in promoting periodontal bone regeneration by reshaping the inflammatory microenvironment in FI.
methodsIn this study, a coculture system involving cell pellet and Raw 264.7 cells was established to elucidate the impact of the cell pellet on macrophage polarization. rTGF-β1 and an inhibitor of the TGFβI/II receptor (LY2109761) were used to investigate the underlying mechanisms of macrophage polarization. Finally, in vivo studies were conducted by implanting the cell pellet into a rat tooth root fenestration defect model to assess its regenerative potential and immunomodulatory effects.
resultsWhen cocultured with macrophages, the cell pellet was observed to polarize the macrophages toward the M2 phenotype. This effect could be counteracted by the use of a TGF-β receptor inhibitor. In vivo studies have shown that the cell pellet effectively transitions proinflammatory M1 macrophages into a pro-healing M2 phenotype, restores the M2/M1 ratio to a physiological balance, efficiently resolves inflammatory responses, and ultimately augments osteoblastic differentiation and promotes bone regeneration.
conclusionCell pellets promote periodontal regeneration by orchestrating M2 macrophage polarization via paracrine TGF-β1, suggesting a scaffold-free strategy that integrates immunomodulation and structural support for FI treatment. CLINICAL SIGNIFICANCE: This study provides a novel scaffold-free therapeutic option for furcation involvement, addressing the clinical bottleneck of insufficient immunomodulation and limited regenerative efficacy of traditional treatments. The TGF-β1-mediated immunomodulatory and regenerative effects of cell pellets offer a promising approach to improve functional periodontal tissue restoration and tooth preservation in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.